CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory

Abstract

Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. Methods: Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (⩽45). Results: Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being ( r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores predicted increases in well-being and Challenging Experience Questionnaire scores predicted less increases. Conclusions: Here we validate a six-item ‘Emotional Breakthrough Inventory’. Emotional breakthrough is an important and distinct component of the acute psychedelic experience that appears to be a key mediator of subsequent longer-term psychological changes. Implications for psychedelic therapy are discussed.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881119855974

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 65 references

Research works printed but not linked: 16

  1. Abramson HA, 1960, The Use of LSD in Psychotherapy: Transactions
  2. Barrett FS, 2018, Int Rev Psychiatry, 1
  3. Belser A (2016) Real, Relational, and Embodied: The First Qualitative Study of Patient Experiences of Psilocybin-Assisted Psychotherapy. In: Interdisciplinary Conference on Psychedelics Research (ICPR), 6 June 2016. Amsterdam. Youtube–Available at: https://www.youtube.com/watch?v=DUYDjV8lQxo
  4. Breuer J, 1895, Studies on Hysteria
  5. Dittrich A, 1975, Z Klin Psychol Psychiatr Psychother, 23, 12
  6. Fisher FM, 2015, Therapy with Substance: Psycholytic Psychotherapy in the Twenty First Century
  7. Grof S, 1980, LSD Psychotherapy (The healing potential of psychedelic medicine)
  8. Huxley A, 1945, The Perennial Philosophy
  9. Hyde RW, 1960, Dynamics of Psychiatric Drug Therapy, 297
  10. Johnson MW, 2016, Am J Drug Alcohol Abuse, 1
  11. Katzenelbogen S, 1953, Dis Nerv Syst, 14, 85
  12. Kurland AA, 1972, J Thanatol, 2, 644
  13. Leuner H, 1961, Hallucinogenic Drugs, 67, 67
  14. Loizaga-Velder A, 2013, MAPS Bull, 23, 36
  15. Pahnke WN, 1969, Curr Psychiatr Ther, 9, 144
  16. Sandison R, 1955, Nurs Mirror, 100, 1529

Cited by

See all 413

Metadata

Authors
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R.
Affiliations
Imperial College London (GB)
Corresponding author
Roseman, Leor
Venue
Journal of Psychopharmacology
Published
2019-07-11
Volume
33
Issue
9
Pages
1076-1087
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2962285119
Cited by
413
References
65
Citations by year
2026: 67 · 2025: 77 · 2024: 87 · 2023: 72 · 2022: 52 · 2021: 37 · 2020: 20
FWCI
31.80
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wavepaths
  • Ad Astra Chandaria Foundation
  • imperial college london
  • Alex Mosley Charitable Trust
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
  • Social Sciences › Health › Religion, Spirituality, and Psychology
Keywords
psychedelics, psychedelic therapy, mystical experience, well-being, psychological change, treatment planning
MeSH terms
Adult, Emotions, Female, Hallucinogens, Humans, Male, Mysticism, Psilocybin, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. https://app.cochat.ai/papers/10.1177/0269881119855974
The paper
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019). Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. Journal of Psychopharmacology. https://doi.org/10.1177/0269881119855974

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.